Back to search

Denmark· DK-28100713876

Fenylbutazon "OBA"

A phenylbutazone product containing phenylbutazon, registered in Denmark by Oba-Pharma ApS. The same ATC class is registered in 4 of our 19 countries.

ATC M01AA01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedFenylbutazon "OBA"ATCM01AA01REGISTER NO.DK-28100713876PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Phenylbutazone is registered in 4 of 19 countries.

Countries holding a registration under ATC M01AA01 (phenylbutazone), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 2 of them publish a price we can compare per daily dose

Phenylbutazone · ATC M01AA01

4 / 19 countries

  • Denmark
  • Finlandprice
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
PHENYLBUTAZON
Manufacturer
Oba-Pharma ApS
Country
Denmark (DK)
ATC code
M01AA01
ATC class
Phenylbutazone
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28100713876

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

298 interactions on record for phenylbutazone.

Graded by severity as the source publishes them — 48 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Phenylbutazone · interactions on record

298 records

  • 48 severe
  • 242 moderate
  • 8 minor

Most severe, free to view

  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • PrasugrelB01AC22severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/74991772-bc4d-4bb6-822f-90be0fc24ce0
GET /v1/drugs/74991772-bc4d-4bb6-822f-90be0fc24ce0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "200 mg",
  "auth_role": "DKMA",
  "dk_drugid": "28100713876",
  "substance": "PHENYLBUTAZON",
  "auth_procedure": "National",
  "in_medicinpriser": false,
  "registration_date_serial": "28108"
}

See everything about phenylbutazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.